硼中子俘获治疗胶质母细胞瘤后小细胞外囊泡中miRNA的谱分析
该研究对经硼中子俘获治疗(BNCT)处理的胶质母细胞瘤U87 MG细胞释放的小细胞外囊泡(sEVs)中的miRNA进行芯片分析,发现20种miRNA升高(比值>2)、2种降低(比值<0.5);TCGA总生存分析显示其中20种miRNA与胶质瘤预后更差相关。
要点
- BNCT处理后U87 MG细胞sEVs中20种miRNA升高(比值>2)、2种降低(比值<0.5)。
- TCGA总生存分析中,20种升高的miRNA与胶质瘤预后更差相关。
- 作者认为这些miRNA可能促进肿瘤进展、调节放疗抵抗或抑制侵袭并影响预后。
核心结论
- BNCT后这些miRNA可能促进肿瘤进展、调节放疗抵抗或抑制侵袭,并影响胶质瘤预后。
研究设计与样本
- 胶质母细胞瘤U87 MG细胞在含25 ppm BPA的培养基中处理并接受热中子照射,照后培养3天后收集sEVs并用芯片全面检测miRNA。
主要发现
- 与未照射细胞相比,BNCT细胞中20种miRNA升高(比值>2),2种miRNA降低(比值<0.5)。
- TCGA总生存Kaplan-Meier分析中,检测到的20种miRNA与胶质瘤预后更差相关。
关键数值与推荐
- miRNA升高判定比值为>2,降低判定比值为<0.5。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Boron neutron capture therapy (BNCT) is a tumor cell-selective particle-radiation therapy. In BNCT, administered p-boronophenylalanine (BPA) is selectively taken up by tumor cells, and the tumor is irradiated with thermal neutrons. High-LET α-particles and recoil 7Li, which have a path length of 5-9 μm, are generated by the capture reaction between 10B and thermal neutrons and selectively kill tumor cells that have uptaken 10B. Although BNCT has prolonged the survival time of malignant glioma patients, recurrences are still to be resolved. miRNAs, that are encapsulated in small extracellular vesicles (sEVs) in body fluids and exist stably may serve critical role in recurrence. In this study, we comprehensively investigated microRNAs (miRNAs) in sEVs released from post-BNCT glioblastoma cells. METHOD: Glioblastoma U87 MG cells were treated with 25 ppm of BPA in the culture media and irradiated with thermal neutrons. After irradiation, they were plated into dishes and cultured for 3 days in the 5% CO2 incubator. Then, sEVs released into the medium were collected by column chromatography, and miRNAs in sEVs were comprehensively investigated using microarrays. RESULT: An increase in 20 individual miRNAs (ratio > 2) and a decrease in 2 individual miRNAs (ratio < 0.5) were detected in BNCT cells compared with non-irradiated cells. Among detected miRNAs, 20 miRNAs were associated with worse prognosis of glioma in Kaplan Meier Survival Analysis of overall survival in TCGA. CONCLUSION: These miRNA after BNCT may proceed tumors, modulate radiation resistance, or inhibit invasion and affect the prognosis of glioma.
引用
- Kondo N, Kinouchi T, Natsumeda M, et al. Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy. J Neurooncol. 2024. PMID: 38598087. doi:10.1007/s11060-024-04649-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。